Korean J Perinatol.  2008 Mar;19(1):37-41.

Positive seroconversion rate of hepatitis B antibody after hepatitis B vaccination by birth weight and gestational age

Affiliations
  • 1Department of pediatrics, IL Sin Christian Hospital, Busan, Korea. zzz-78@hanmail.net

Abstract


OBJECTIVE
Previous studies have reported that the immune response of hepatitis B vaccine is decreased in preterm or low birth weight babies compared to healthy term babies. To evaluate this notion, we investigated the positive seroconversion rate of hepatitis B antibody after hepatitis B vaccination according to gestational age and birth weight.
METHODS
We retrospectively studied medical records about the positive seroconversion rate of a total of 968 infants who were given DNA recombinant hepatitis B vaccine as scheduled at Il Sin Christian Hospital, Busan from January 2002 to Mar 2007.
RESULTS
The postive seroconversion failure rate (non-responder or poor-responder) of hepatitis B antibody by gestational age was 15.6% (<28 weeks), 11.4% (>28 weeks, <32 weeks), 5.8% (>32 weeks, <37 weeks), and 1.9% (<37 weeks). The postive seroconversion failure rate by birth weight was 16.7% (< 1,000 g), 15% (>1,000 g, <1,500 g), 5% (>1,500 g, <2,000 g), and 2% (>2,000 g).
CONCLUSION
The seropositive rate of hepatitis B antibody after hepatitis B vaccination decreased as the gestational age and the birth weight decreased. And gestational age more than 37 weeks and birth weight above 2,000 g were independently associated with a higher seropositive rate of hepatitis B antibody after hepatitis B vaccination.

Keyword

Seroconversion; Hepatitis B antibody; Gestational age; Birth weight

MeSH Terms

Birth Weight
DNA
Gestational Age
Hepatitis
Hepatitis B
Hepatitis B Vaccines
Humans
Infant
Infant, Low Birth Weight
Infant, Newborn
Medical Records
Parturition
Retrospective Studies
Vaccination
DNA
Hepatitis B Vaccines
Full Text Links
  • KJP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr